Doubao Mobile Assistant has launched a consumer version.

A summit to formalise a post-Brexit reset between the UK and EU, originally scheduled for July 22 and briefly moved to Nov. 6, has been delayed again and is now unlikely before late November, two EU officials told the Financial Times. UK ministers say the meeting must address new Prime Minister Andy Burnham’s objections to an EU 'European-made' procurement policy that would prioritise EU-made goods in some public and corporate contracts. The UK government says the measure could damage manufacturing sectors including autos and chemicals.

At its Sept. 14, 2026 interim results briefing, Junshi Biosciences said JS203 (CD20/CD3 bispecific) is expected to initiate Phase III trials in 2026. JS207 (PD-1/VEGF bispecific) is in Phase II and is being tested in combination with chemotherapy, monoclonal antibodies and ADCs across multiple tumor types; Junshi plans to start Phase III for JS207 in 2026.